TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Strata Skin Sciences ( (SSKN) ) just unveiled an announcement.
Strata Skin Sciences, Inc. received a deficiency notification from Nasdaq on August 22, 2025, for not meeting the minimum stockholders’ equity requirement of $2,500,000 for continued listing on the Nasdaq Capital Market. On October 13, 2025, Nasdaq accepted the company’s compliance plan, granting an extension until February 16, 2026, to meet the requirement. The company is exploring options to regain compliance, but failure to do so could result in delisting, with the possibility to appeal any delisting decision.
The most recent analyst rating on (SSKN) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Strata Skin Sciences stock, see the SSKN Stock Forecast page.
Spark’s Take on SSKN Stock
According to Spark, TipRanks’ AI Analyst, SSKN is a Neutral.
Strata Skin Sciences faces significant financial challenges, with persistent losses and declining equity being the most impactful factors. Technical analysis shows mixed signals, with some bullish momentum but overall resistance. Valuation is weak due to negative earnings and no dividend yield. The earnings call highlighted potential growth opportunities, but these have yet to translate into improved financial performance.
To see Spark’s full report on SSKN stock, click here.
More about Strata Skin Sciences
Average Trading Volume: 2,864,798
Technical Sentiment Signal: Sell
Current Market Cap: $8.11M
For detailed information about SSKN stock, go to TipRanks’ Stock Analysis page.